Choroidal neovascularization secondary to tuberculosis: Presentation and management

Article Properties
Cite
Lee Kim, Esther, et al. “Choroidal Neovascularization Secondary to Tuberculosis: Presentation and Management”. American Journal of Ophthalmology Case Reports, vol. 5, 2017, pp. 124-9, https://doi.org/10.1016/j.ajoc.2016.12.025.
Lee Kim, E., Rodger, D. C., & Rao, N. A. (2017). Choroidal neovascularization secondary to tuberculosis: Presentation and management. American Journal of Ophthalmology Case Reports, 5, 124-129. https://doi.org/10.1016/j.ajoc.2016.12.025
Lee Kim, Esther, Damien C. Rodger, and Narsing A. Rao. “Choroidal Neovascularization Secondary to Tuberculosis: Presentation and Management”. American Journal of Ophthalmology Case Reports 5 (2017): 124-29. https://doi.org/10.1016/j.ajoc.2016.12.025.
Lee Kim E, Rodger DC, Rao NA. Choroidal neovascularization secondary to tuberculosis: Presentation and management. American Journal of Ophthalmology Case Reports. 2017;5:124-9.
Refrences
Title Journal Journal Categories Citations Publication Date
The use of corticosteroids for choroidal neovascularisation in young patients Eye
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
65 1998
Replication ofMycobacterium Tuberculosisin Retinal Pigment Epithelium JAMA Ophthalmology
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
  • Medicine: Medicine (General)
39 2014
Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results Acta Ophthalmologica
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
33 2011
Local Ischemia and Increased Expression of Vascular Endothelial Growth Factor Following Ocular Dissemination of Mycobacterium tuberculosis PLOS ONE
  • Medicine
  • Science
  • Science: Science (General)
35 2011
Experimental Ocular Tuberculosis in Guinea Pigs Archives of Ophthalmology 32 2009
Refrences Analysis
The category Medicine: Medicine (General) 3 is the most frequently represented among the references in this article. It primarily includes studies from Archives of Ophthalmology and JAMA Ophthalmology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy Bioorganic Chemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry
  • Science: Chemistry: Analytical chemistry
  • Technology: Chemical technology: Polymers and polymer manufacture
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
2024
Ocular Tuberculosis Choroidal Granuloma with Unusual Recurrent Choroidal Neovascularization

Journal of Evolution of Medical and Dental Sciences 2022
Subfoveal retinal pigment epithelium inflammatory lesion presenting as a sign of reactivation of tubercular multifocal choroiditis

BMJ Case Reports
  • Medicine: Medicine (General)
1 2021
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis

Frontiers in Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
18 2021
The Use of Optical Coherence Tomography Angiography in the Diagnosis of Inflammatory Type 1 Choroidal Neovascularization Secondary to Tuberculosis: A Case Report Ocular Immunology and Inflammation
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
2 2020
Citations Analysis
The category Medicine: Medicine (General) 5 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management and was published in 2018. The most recent citation comes from a 2024 study titled The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy. This article reached its peak citation in 2020, with 5 citations. It has been cited in 11 different journals, 27% of which are open access. Among related journals, the Bioorganic Chemistry cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year